oxaprozin has been researched along with Rheumatoid Arthritis in 12 studies
Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy and safety of leflunomide (LEF) in the treatment of rheumatoid arthritis (RA) were evaluated and the comparison with methotrexate's (MTX's) was performed in a 12-week, single-blind, randomized, parallel trial for treating 81 patients with RA." | 9.09 | A randomized, controlled, single-blind trial of leflunomide in the treatment of rheumatoid arthritis. ( Hu, Y; Liu, P; Tu, S, 2001) |
| "Oxaprozin, an anti-inflammatory agent with a half-life of 50 hours, was compared in regard to efficacy and tolerance with sulindac in a 12-week double-blind parallel treatment trial of rheumatoid arthritis." | 9.05 | Oxaprozin and sulindac in rheumatoid arthritis: a double-blind comparative trial. ( Fraser, KM; Hall, SM; Mackinnon, MJ; Palmer, DG; Zuccollo, R, 1983) |
| "We describe a case of Stevens-Johnson syndrome (SJS) associated with oxaprozin ("Daypro"), a relatively new nonsteroidal antiinflammatory drug (NSAID) of the propionic acid group." | 7.70 | A case of Stevens-Johnson syndrome associated with oxaprozin therapy. ( Bell, MJ; Bishara, LD, 1998) |
| "The efficacy and safety of leflunomide (LEF) in the treatment of rheumatoid arthritis (RA) were evaluated and the comparison with methotrexate's (MTX's) was performed in a 12-week, single-blind, randomized, parallel trial for treating 81 patients with RA." | 5.09 | A randomized, controlled, single-blind trial of leflunomide in the treatment of rheumatoid arthritis. ( Hu, Y; Liu, P; Tu, S, 2001) |
| "The incidence of potentially serious drug-related elevations of BUN or serum creatinine was examined among 1468 patients with rheumatoid arthritis or osteoarthritis who took daily therapeutic doses of aspirin, ibuprofen, or oxaprozin, an investigational nonsteroidal antiinflammatory drug (NSAID), in multicenter clinical trials." | 5.06 | Renal safety of two analgesics used over the counter: ibuprofen and aspirin. ( Bonney, SL; Hedrich, DA; Northington, RS; Walker, BR, 1986) |
| "Oxaprozin, an anti-inflammatory agent with a half-life of 50 hours, was compared in regard to efficacy and tolerance with sulindac in a 12-week double-blind parallel treatment trial of rheumatoid arthritis." | 5.05 | Oxaprozin and sulindac in rheumatoid arthritis: a double-blind comparative trial. ( Fraser, KM; Hall, SM; Mackinnon, MJ; Palmer, DG; Zuccollo, R, 1983) |
| "We describe a case of Stevens-Johnson syndrome (SJS) associated with oxaprozin ("Daypro"), a relatively new nonsteroidal antiinflammatory drug (NSAID) of the propionic acid group." | 3.70 | A case of Stevens-Johnson syndrome associated with oxaprozin therapy. ( Bell, MJ; Bishara, LD, 1998) |
| "Oxaprozin is a nonsteroidal anti-inflammatory drug characterised by a propionic acid-based structure." | 2.43 | A review of the emerging profile of the anti-inflammatory drug oxaprozin. ( Bertolotto, M; Dallegri, F; Ottonello, L, 2005) |
| "Oxaprozin is an effective, long-acting anti-inflammatory analgesic, but its comparative advantages remain undefined." | 2.39 | A review of selected newer nonsteroidal anti-inflammatory drugs. ( Amadio, P; Cummings, DM, 1994) |
| "Oxaprozin (Wy-21743) is a novel and unique compound among NSAIDs: it bears an aliphatic propionic acid function as a side chain in contrast to the large group of acetic acids and profens." | 1.28 | The transsynovial distribution of oxaprozin. ( Kurowski, M; Thabe, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, W | 1 |
| Wang, YM | 1 |
| Cheng, NN | 1 |
| Chen, BY | 1 |
| Li, D | 1 |
| Dallegri, F | 1 |
| Bertolotto, M | 1 |
| Ottonello, L | 1 |
| Zuccollo, R | 1 |
| Mackinnon, MJ | 1 |
| Fraser, KM | 1 |
| Hall, SM | 1 |
| Palmer, DG | 1 |
| Schorn, D | 1 |
| Cummings, DM | 1 |
| Amadio, P | 1 |
| Bell, MJ | 1 |
| Bishara, LD | 1 |
| Bellamy, N | 1 |
| Campbell, J | 1 |
| Syrotuik, J | 1 |
| Hu, Y | 1 |
| Tu, S | 1 |
| Liu, P | 1 |
| al-Faks, MA | 1 |
| Pugh, MC | 1 |
| Kurowski, M | 1 |
| Thabe, H | 1 |
| Bonney, SL | 1 |
| Northington, RS | 1 |
| Hedrich, DA | 1 |
| Walker, BR | 1 |
4 reviews available for oxaprozin and Rheumatoid Arthritis
| Article | Year |
|---|---|
[Meta-analysis on the effect and adverse reaction on patients with osteoarthritis and rheumatoid arthritis treated with non-steroidal anti-inflammatory drugs].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Butanones; China; Diclofenac; Humans | 2003 |
A review of the emerging profile of the anti-inflammatory drug oxaprozin.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Industry; Humans; Oxap | 2005 |
A review of selected newer nonsteroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Butanones; Clinical Trials as Topic; | 1994 |
Oxaprozin: a new NSAID.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Double-Blind Method; Half-Life; Huma | 1992 |
4 trials available for oxaprozin and Rheumatoid Arthritis
| Article | Year |
|---|---|
Oxaprozin and sulindac in rheumatoid arthritis: a double-blind comparative trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind | 1983 |
A comparison between oxaprozin and naproxen in rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Fema | 1981 |
A randomized, controlled, single-blind trial of leflunomide in the treatment of rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Hum | 2001 |
Renal safety of two analgesics used over the counter: ibuprofen and aspirin.
Topics: Adult; Aged; Arthritis, Rheumatoid; Aspirin; Blood Urea Nitrogen; Clinical Trials as Topic; Creatini | 1986 |
4 other studies available for oxaprozin and Rheumatoid Arthritis
| Article | Year |
|---|---|
Oxaprozin for arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Humans; Osteoarthritis; Oxaprozin; P | 1993 |
A case of Stevens-Johnson syndrome associated with oxaprozin therapy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Humans; Middle Aged; Oxaproz | 1998 |
Comparative study of self-rating pain scales in rheumatoid arthritis patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Eval | 1999 |
The transsynovial distribution of oxaprozin.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Humans; Male; M | 1989 |